logo
[breadcrumb_custom]

Tag: NKTR

CROX
News

NKTR’s Stock Market Puzzle: Piecing Together 2023’s Performance

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 195.58%. However, over the last six months, the performance has been weaker by 219.56%. The price of NKTR increased 96.47% over the last 30 days. And in the last five days, it has surged by 26.52%. The market performance of Nektar Therapeutics’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $1.75 on 04/11/24, while the lowest

News

NKTR’s Market Whiplash: 121.24% YTD Rise, 37.50% Rise in 30 Days

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 121.24% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 131.05%. Over the past 30 days, the price of NKTR has fallen by 37.50%. And in the last five days, it has surged by 31.58%. Nektar Therapeutics experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $1.47 on 04/05/24, while the

Industry

Behind Nektar Therapeutics’s 52-Week Range: Uncovering Opportunities for Investors

The market performance of Nektar Therapeutics has been somewhat stable. Over the past year, the company’s stock achieved a high of $1.12 on 08/07/23, with the lowest value for the same timeframe being $0.41, recorded on 11/13/23. 52-week price history of NKTR Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Nektar Therapeutics’s current trading price is -15.18% away from its 52-week high, while its distance from the 52-week low is 130.25%. The stock’s price range for this period has remained between

News

Nektar Therapeutics Inc. (NKTR) Price Performance: A Comparative Analysis with Competitors

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a gain of 57.52%.However, over the last six months, we can see a weaker performance of 36.92%. Over the last 30 days, the price of NKTR has fallen by 25.35%. And in the last five days, it has surged by 0.67%. The market performance of Nektar Therapeutics’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.25 on

ELVT Stock
Stock

Nektar Therapeutics’s Shares Reel: 90.02% Quarterly Revenue Decline Amid 177.63M Market Cap

The market performance of Nektar Therapeutics’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.60 on 03/06/23, while the lowest value for the same duration was $0.41 on 11/13/23. 52-week price history of NKTR Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Nektar Therapeutics’s current trading price is -41.81% away from its 52-week high, while its distance from the 52-week low is 125.67%. The stock’s price range during the 52-week period has remained

ZM Stock
Industry

Nektar Therapeutics (NKTR) Stock: 52-Week Performance Insights and Trading Volume

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Nektar Therapeutics’s current trading price is -53.13% away from its 52-week high, while its distance from the 52-week low is 81.77%. The stock’s price range for this time frame has been between $0.41 and $1.60. The trading volume of the company’s shares in the Healthcare reached around 1.85 million for the day, which was evidently higher than the average daily volume of 1.21 million over the last three months. The market performance of Nektar Therapeutics has been somewhat unstable.